SubHero Banner

Temixys (lamivudine/tenofovir disoproxil fumarate) – New drug approval

November 16, 2018 - The FDA approved Celltrion’s Temixys (lamivudine/tenofovir disoproxil fumarate), to be used in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 35 kg.

Download PDF